Ardmore, PA, United States of America

Danielle Jernigan

This inventor holds 1 USPTO granted patent. Top assignee: Drexel University. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Danielle Jernigan

Introduction

Danielle Jernigan is a prominent inventor based in Ardmore, PA (US). She has made significant strides in the field of medical research, particularly in cancer treatment. Her work focuses on innovative methods to combat prostate cancer, a condition that affects many individuals worldwide.

Latest Patents

Danielle holds a patent for a groundbreaking invention titled "Method of treating androgen receptor negative prostate tumors and their metastases." This invention includes a method of preventing or treating metastasis in a subject diagnosed with prostate cancer. In certain embodiments, the metastasis comprises bone cancer. In other embodiments, the subject suffers from castration-resistant prostate cancer. This patent highlights her commitment to advancing cancer treatment options.

Career Highlights

Danielle Jernigan is affiliated with Drexel University, where she contributes to research and development in the medical field. Her role at the university allows her to collaborate with other experts and push the boundaries of current medical knowledge.

Collaborations

Danielle has worked alongside notable colleagues, including Alessandro Fatatis and Fei Shen. Their combined expertise enhances the research efforts and leads to innovative solutions in cancer treatment.

Conclusion

Danielle Jernigan's contributions to the field of cancer research are invaluable. Her innovative patent and collaboration with esteemed colleagues reflect her dedication to improving patient outcomes. Through her work, she continues to inspire future advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…